低分子肝素钠+辛伐他汀用于冠心病心绞痛治疗临床分析

摘要

Objective To analyze and research for patients with angina pectoris simvastatin clinical value of low molecular weight heparin. Methods Group selection from October 2014 to December 2015 in patients with angina pectoris in to the Affiliated Hospital of Chifeng College treatment of 126 cases for the study of this report are divided into two groups, each group 63 cases. In the control group were treated with angina pectoris clinical routine drug treatment, the test group of pa-tients with angina pectoris simvastatin combined with low molecular weight heparin to intervene. After treatment, the num-ber of clinical parameters, duration compared two groups of patients with angina pectoris, the heart rate, cholesterol, triglyc-erides, angina. Results The experimental group after treatment clinical parameters in patients with angina pectoris angina cases, heart rate, cholesterol, triglycerides and other than the control group, the difference was significant, statistically sig-nificant, P<0.05. Conclusion Simvastatin combined with low molecular weight heparin has a good effect on the value in the clinical treatment of coronary heart disease, can significantly improve the indicators of angina pectoris patients during treat-ment, reducing the occurrence of angina.%目的：分析和研究针对冠心病心绞痛患者应用辛伐他汀结合低分子肝素钠的临床价值。方法整群选取2014年10月-2015年12月来赤峰学院附属医院治疗的冠心病心绞痛患者126例作为此次报告的研究对象,均分成两组,每组63例。对照组冠心病心绞痛患者给予临床常规药物进行治疗,而试验组冠心病心绞痛患者应用辛伐他汀结合低分子肝素钠进行干预。治疗结束后对比两组患者心绞痛情况、心率、胆固醇、甘油三酯、心绞痛发生次数、持续时间等临床指标。结果试验组冠心病心绞痛患者治疗后心绞痛情况、心率、胆固醇、甘油三酯等临床指标均优于对照组,差异具有统计学意义,P<0.05。结论辛伐他汀结合低分子肝素钠在临床治疗冠心病上有着较好的作用价值,可以明显的改善冠心病心绞痛患者治疗期间的各项指标,减少了心绞痛的发生。